Company: HURA
Filing Date: 2025-08-12
Form Type: S-1
Source: 0001193125-25-179009
Chunk: 326

Company: TuHURA Biosciences, Inc./NV
Filing Date: 2025-08-12
Form: S-1
Chunk 326
---
 Receivable          |     |   |          222,702 |     |   |                — |
| Clinical trial deposit        |     |   |          204,955 |     |   |                — |
| Other current assets          |     |   |          316,352 |     |   |          159,326 |
|                               |     | $ |          958,708 |     | $ |          493,769 |

Note 8-Propertyand equipment, net

Property and equipment, net consists of the following as of December 31, 2024, and 2023:

|                                |     |   | December 31,2024 |     |   | December 31,2023 |
|:-------------------------------|:----|:--|-----------------:|:----|:--|-----------------:|
| Furniture and fixtures         |     | $ |          170,607 |     | $ |          170,607 |
| Leasehold improvements         |     |   |          544,629 |     |   |          544,628 |
| Machinery and office equipment |     |   |        1,423,183 |     |   |        1,365,277 |
| Software                       |     |   |           72,394 |     |   |           72,394 |

<div align='center'>F-8 4</div>

TUHURA BIOSCIENCES, INC AND SUBSIDIARIES Notes to the consolidated financial statements For the years ended December 31, 2024, and 2023

| Less accumulated depreciation and amortization |     | December 31,2024 |  2,210,813 
 (2,087,447 | ) |     | December 31,2023 |  2,152,906 
 (1,970,736 | ) |
|:-----------------------------------------------|:----|:-----------------|-----------:|:--|:----|:-----------------|-----------:|:--|
|                                                |     | $                |    123,366 |   |     | $                |    182,170 |   |

Depreciation and amortization of property and equipment totaled approximately $ 117,000 and $ 177,000 for the years ended December 31, 2024, and 2023, respectively.

Note 9-Accountspayable and accrued expenses

Accounts payable and accrued expenses